ENTITY
Pacific Edge

Pacific Edge (PEB NZ)

67
Analysis
Health Care • New Zealand
Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.
more
bullish•Pacific Edge
•03 Dec 2022 08:01•Broker

Pacific Edge: 1H23 Result — In the Waiting Room

Pacific Edge's (PEB) 1H23 result reaffirmed the ongoing solid underlying revenue momentum in the business, but showed a material step-up in costs...

Logo
349 Views
Share
bullish•Pacific Edge
•01 Dec 2022 08:01•Broker

Pacific Edge (PEB): 1H23 Result – Initial Impressions

Pacific Edge (PEB) reported a 1H23 reported revenue result ahead of our expectations with revenue of NZ$13.6m versus our NZ$9.4m driven by strong...

Logo
423 Views
Share
bullish•Pacific Edge
•24 Oct 2022 06:23•Broker

Pacific Edge (PEB): 2Q23 Update – Solid Momentum Continues

Pacific Edge’s (PEB) 2Q23 test volumes highlight ongoing solid momentum with +11% sequential growth versus 1Q23 and +36% year on year

Logo
300 Views
Share
bullish•Pacific Edge
•17 Aug 2022 12:39•Broker

Pacific Edge: Balanced On a Knife's Edge

PEB confirmed notification of the inclusion of Cxbladder CPT codes in a draft proposal for a different approach to determine which cancer biomarker...

Logo
342 Views
Share
bullish•Pacific Edge
•27 Jul 2022 08:03•Broker

Pacific Edge (PEB): 1Q23 Update

Pacific Edge (PEB)   1Q23 Update Pacific Edge (PEB) has this morning provided a detailed investor update, including 1Q23 lab throughput numbers....

Logo
534 Views
Share
x